HIF-2α affects proliferation and apoptosis of MG-63 osteosarcoma cells through MAPK signaling

Wang,Yuqiang; Wang,Xiaohua; Su,Xuetao; Liu,Tiansheng

doi:10.3892/mmr.2017.6243

HIF-2α affects proliferation and apoptosis of MG-63 osteosarcoma cells through MAPK signaling

Authors:
- Yuqiang Wang
- Xiaohua Wang
- Xuetao Su
- Tiansheng Liu
View Affiliations

Affiliations: Department of Orthopedic Surgery, The Affiliated Hospital of Logistics College of Chinese People's Armed Police Force, Pingjin Hospital, Tianjin 300162, P.R. China, Department of Neurological Intensive Care Unit, Tianjin Huanhu Hospital, Tianjin 300060, P.R. China
Published online on: February 23, 2017 https://doi.org/10.3892/mmr.2017.6243
Pages: 2174-2178
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study explored the mechanism of hypoxia-inducible factor (HIF)‑2α in proliferation and apoptosis of the osteosarcoma cell line, MG‑63. Cells were treated with small interfering RNA (siRNA) against HIF‑2α (silenced group) or without siRNA (control group). Cell viability of MG‑63 in the silenced and the control groups was determined by MTT assay; cell apoptosis was measured by flow cytometry; the expression of HIF‑2α and mitogen-activated protein kinase (MAPK)-p38 were measured by western blotting. According to MTT assay, 48 h after siRNA transfection, compared with the control group, cells in the silenced group significantly declined in quantity and the number of apoptotic cells increased significantly. The expression of HIF‑2α and MAPK‑p38 were significantly decreased (P<0.05). In conclusion, knockdown of HIF-2α in the osteosarcoma cell line reduced the proliferation of cancer cells and increased apoptosis. These effects likely occurred through the MAPK‑p38 signaling pathway.

View Figures

View References

1	Vaupel P and Mayer A: Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev. 26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
2	Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, et al: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107:43–54. 2001. View Article : Google Scholar : PubMed/NCBI
3	Schönenberger D, Rajski M, Harlander S and Frew IJ: Vhl deletion in renal epithelia causes HIF-1α-dependent, HIF-2α-independent angiogenesis and constitutive diuresis. Oncotarget. Aug 12–2016.(Epub ahead of print). View Article : Google Scholar
4	Triner D and Shah YM: Hypoxia-inducible factors: A central link between inflammation and cancer. J Clin Invest. 126:3689–3698. 2016. View Article : Google Scholar : PubMed/NCBI
5	Guo XF, Wang AY and Liu J: HIFs-MiR-33a-Twsit1 axis can regulate invasiveness of hepatocellular cancer cells. Eur Rev Med Pharmacol Sci. 20:3011–3016. 2016.PubMed/NCBI
6	Nauta TD, Duyndam MC, Weijers EM, van Hinsbergh VM and Koolwijk P: HIF-2α Expression regulates sprout formation into 3D fibrin matrices in prolonged hypoxia in human microvascular endothelial cells. PLoS One. 11:e01607002016. View Article : Google Scholar : PubMed/NCBI
7	Nepal M, Gong YD, Park YR and Soh Y: An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1α. Cell Biochem Funct. 29:126–134. 2011. View Article : Google Scholar : PubMed/NCBI
8	Gao Y, Li H, Ma X, Fan Y, Ni D, Zhang Y, Huang Q, Liu K, Li X, Wang L, et al: E2F3 upregulation promotes tumor malignancy through the transcriptional activation of HIF-2α in clear cell renal cell carcinoma. Oncotarget. Jul 13–2016.(Epub ahead of print).
9	Harris AL: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
10	Mizobuchi H, García-Castellano JM, Philip S, Healey JH and Gorlick R: Hypoxia markers in human osteosarcoma: An exploratory study. Clin Orthop Relat Res. 466:2052–2059. 2008. View Article : Google Scholar : PubMed/NCBI
11	Kaelin WG Jr: How oxygen makes its presence felt. Genes Dev. 16:1441–1445. 2002. View Article : Google Scholar : PubMed/NCBI
12	Qu WR, Wu J and Li R: Contribution of the GSTP1 gene polymorphism to the development of osteosarcoma in a Chinese population. Genet Mol Res. 15:152016. View Article : Google Scholar
13	Bertout JA, Majmundar AJ, Gordan JD, Lam JC, Ditsworth D, Keith B, Brown EJ, Nathanson KL and Simon MC: HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc Natl Acad Sci USA. 106:14391–14396. 2009. View Article : Google Scholar : PubMed/NCBI
14	Ben-Shoshan J, Schwartz S, Luboshits G, Maysel-Auslender S, Barzelay A, Polak-Charcon S, Tzahor E, Barshack I, Barak A, Levkovitch-Verbin H, et al: Constitutive expression of HIF-1α and HIF-2α in bone marrow stromal cells differentially promotes their proangiogenic properties. Stem Cells. 26:2634–2643. 2008. View Article : Google Scholar : PubMed/NCBI
15	Fang Z, Tang Y, Jiao W, Xing Z, Guo Z, Wang W, Xu Z and Liu Z: Nitidine chloride induces apoptosis and inhibits tumor cell proliferation via suppressing ERK signaling pathway in renal cancer. Food Chem Toxicol. 66:210–216. 2014. View Article : Google Scholar : PubMed/NCBI
16	Knowles HJ, Schaefer KL, Dirksen U and Athanasou NA: Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: Regulation and phenotypic effects of hypoxia-inducible factor. BMC Cancer. 10:3722010. View Article : Google Scholar : PubMed/NCBI
17	Chatterjee B, Wolff DW, Jothi M, Mal M and Mal AK: p38α MAPK disables KMT1A-mediated repression of myogenic differentiation program. Skelet Muscle. 6:282016. View Article : Google Scholar : PubMed/NCBI
18	Faber AC, Coffee EM, Costa C, Dastur A, Ebi H, Hata AN, Yeo AT, Edelman EJ, Song Y, Tam AT, et al: mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1. Cancer Discov. 4:42–52. 2014. View Article : Google Scholar : PubMed/NCBI
19	Hua S and Dias TH: Hypoxia-Inducible Factor (HIF) as a target for novel therapies in rheumatoid arthritis. Front Pharmacol. 7:1842016. View Article : Google Scholar : PubMed/NCBI
20	Rogers LJ, Basnakian AG, Orloff MS, Ning B, Yao-Borengasser A, Raj V and Kadlubar S: 2-amino-1-methyl-6-phenylimidazo(4,5-b) pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation, diabetes and cancer. Nutr Metab (Lond). 13:542016. View Article : Google Scholar : PubMed/NCBI
21	Qi K, Li Y, Li X, Lei X, Wang B, Zhang L and Chu X: Id4 promotes cisplatin resistance in lung cancer through the p38 MAPK pathway. Anticancer Drugs. 27:970–978. 2016. View Article : Google Scholar : PubMed/NCBI